Michael Dempsey – Investing in Bleeding Edge Technology – [Invest Like the Best, EP.212]

<p><span style="font-weight: 400;">My guest today is Michael Dempsey, General Partner at Compound. Michael invests in a broad range of areas but has a unique talent for combining brand building and direct customer relationships with technically demanding sectors. Our conversation covers the rise of virtual influencers, robotics, and how to best identify key inflection points in the evolution of new technologies. I hope you enjoy my conversation with Michael Dempsey. </span></p> <p><span style="font-weight: 400;">For the full show notes, transcript, and links to mentioned content, check out the episode page</span> <a href= "https://www.joincolossus.com/episodes/6557836/dempsey-investing-in-bleeding-edge-technology"> <span style="font-weight: 400;">here</span></a><span style= "font-weight: 400;">.</span></p> <p><strong>-----</strong></p> <p><strong>This episode is brought to you by Koyfin, one of the fastest-growing fintech startups. I discovered Koyfin earlier this year when I asked Twitter for the best Bloomberg alternative, and the overwhelming winner was an intriguing new product called Koyfin. </strong></p> <p><strong>Koyfin has tons of high-quality data, powerful functionality, and a nice clean interface. If you’re an individual investor, research analyst, portfolio manager, or financial advisor, you should definitely check them out. Sign up for free at </strong><a href= "https://www.koyfin.com/"><strong>koyfin.com</strong></a><strong>.</strong></p> <p><strong>------</strong></p> <p><strong>This episode is brought to you by MIT Investment Management Company. MITIMCO is the endowment office of MIT. New and small investment funds listen up. MITIMCO is looking to find investors starting funds today.</strong></p> <p><strong>MITIMCO is partnership-driven, long-term focused and has an extensive history of backing investors early in their careers. These partners are key in delivering the outstanding investment returns required to support MIT's pursuit of world-class education, cutting-edge research, and groundbreaki